#National Cancer Institute

The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.

An NCI study finds long-term increased risk of cancer death following a common treatment for hyperthyroidism.

Researchers are interested in combining PARP inhibitors with immunotherapies for pancreatic and other cancers with defects in DNA repair.

But much needs to be done to help cancer survivors live longer and healthier lives.

Researchers are continuing to identify potential biomarkers or specific clinical factors to identify the best candidates for treatments.

These proteins normally act to stop abnormal cell growth, but they can lose this function in cancer cells.

The Childhood Cancer Data Initiative aims to change the course of how cancer in young people is prevented, diagnosed and treated.

Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.

Rates of the subtypes increased among all ethnic groups, and increased the most among black women, who also had the lowest survival rates.

More patients with metastatic cancer and bone metastases are living longer today, so the need to address bone pain has increased.

An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.

A conversation with NCI’s Howard Parnes, MD

Complications of cancer immunotherapy

Even small changes in physical fitness can make it possible for people to maintain their quality of life as cancer progresses.

Given the long timeline needed for human studies, people today should not expect this technology to be proven and fully approved for years.

“The simplicity of this approach means that it is promising to take forward” to a human vaccine, researchers say.